MFC:TSX

Manulife Financial (MFC) is trading at C$45.34, which sits below its 20‑day (C$48.96) and 50‑day (C$50.30) simple moving averages and just under the 200‑day SMA (C$45.92), indicating a short‑term price weakness. However, the 14‑day RSI is around 29, placing the stock in oversold territory, and the MACD line remains bearish beneath its signal, while volume has been trending upward, suggesting a potential bounce off the identified support at C$44.23. The February 2026 earnings release showed a net income of C$5.78 bn, a double‑digit dividend increase to C$0.485 per share and the launch of a 2.5% share‑repurchase program, reinforcing capital return to shareholders. Analyst consensus remains a “Buy” with a median price target of C$56, reflecting confidence in the upside potential.
On the valuation side, MFC’s trailing P/E of 14.8 is well below the industry average of 17.4, and the DCF‑derived fair value of roughly C$175 implies a more than 20% upside from current levels. The dividend yield of 3.98% is supported by a payout ratio near 57% and robust operating cash flow, indicating sustainability. While the stock exhibits a 30‑day volatility of about 26% and a beta near 1, its large market cap, increasing volume and solid liquidity mitigate immediate downside risk, making it an attractive candidate for investors seeking income and modest capital appreciation.